Tuttle Capital Management LLC acquired a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 25,000 shares of the company’s stock, valued at approximately $461,000. Translational Development Acquisition accounts for approximately 2.7% of Tuttle Capital Management LLC’s investment portfolio, making the stock its 9th biggest position.
Translational Development Acquisition Price Performance
NASDAQ:TDACU opened at $10.04 on Tuesday. Translational Development Acquisition Corp. has a fifty-two week low of $10.01 and a fifty-two week high of $10.05.
Translational Development Acquisition Company Profile
Featured Articles
- Five stocks we like better than Translational Development Acquisition
- Upcoming IPO Stock Lockup Period, Explained
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
- Most active stocks: Dollar volume vs share volume
- 3 Stocks to Benefit From China’s Rare Earth Export Ban on U.S.
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.